| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1053082228 |
| P356 | DOI | 10.1046/J.1523-1755.2002.00190.X |
| P698 | PubMed publication ID | 11849452 |
| P5875 | ResearchGate publication ID | 11512793 |
| P50 | author | Marc Grynpas | Q58422663 |
| P2093 | author name string | John R Asplin | |
| Andrew P Evan | |||
| Fredric L Coe | |||
| David A Bushinsky | |||
| Walter R Parker | |||
| Kristen M Alexander | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | calcium oxalate | Q412399 |
| P304 | page(s) | 975-987 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats | |
| P478 | volume | 61 |
| Q34769674 | 1,25(OH)₂D₃ induces a mineralization defect and loss of bone mineral density in genetic hypercalciuric stone-forming rats |
| Q37234726 | 1,25(OH)₂D₃-enhanced hypercalciuria in genetic hypercalciuric stone-forming rats fed a low-calcium diet |
| Q34927076 | Aggregation of Calcium Phosphate and Oxalate Phases in the Formation of Renal Stones. |
| Q36764652 | Calcium oxalate crystal deposition in kidneys of hypercalciuric mice with disrupted type IIa sodium-phosphate cotransporter |
| Q35825152 | Chlorthalidone improves vertebral bone quality in genetic hypercalciuric stone-forming rats |
| Q34265048 | Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management |
| Q46945491 | Continuous infusion of oxalate by minipumps induces calcium oxalate nephrocalcinosis |
| Q41728196 | Determination of urinary lithogenic parameters in murine models orthologous to autosomal dominant polycystic kidney disease |
| Q37298455 | Dissecting the genetic basis of kidney tubule response to hyperoxaluria using chromosome substitution strains |
| Q36314974 | Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria |
| Q46876202 | Effect of bolus and divided feeding on urine ions and supersaturation in genetic hypercalciuric stone-forming rats |
| Q50093952 | Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats |
| Q35156074 | Elevated vitamin D receptor levels in genetic hypercalciuric stone-forming rats are associated with downregulation of Snail |
| Q46415729 | Endogenous oxalogenesis after acute intravenous loading with ethylene glycol or glycine in rats receiving standard and vitamin B6-deficient diets |
| Q26765054 | Experimental models of renal calcium stones in rodents |
| Q36763582 | Genetic basis of renal cellular dysfunction and the formation of kidney stones |
| Q37283787 | Genetic hypercalciuric stone-forming rats have a primary decrease in BMD and strength |
| Q35737408 | High Sodium-Induced Oxidative Stress and Poor Anticrystallization Defense Aggravate Calcium Oxalate Crystal Formation in Rat Hyperoxaluric Kidneys |
| Q39023117 | Histological aspects of the "fixed-particle" model of stone formation: animal studies |
| Q36499630 | Hydroxyproline ingestion and urinary oxalate and glycolate excretion. |
| Q35021708 | Hyperoxaluric calcium nephrolithiasis |
| Q36413105 | Idiopathic hypercalciuria |
| Q91658207 | Increased Osteoclast and Decreased Osteoblast Activity Causes Reduced Bone Mineral Density and Quality in Genetic Hypercalciuric Stone-Forming Rats |
| Q36699784 | Increased biological response to 1,25(OH)(2)D(3) in genetic hypercalciuric stone-forming rats |
| Q35830544 | Modeling hypercalciuria in the genetic hypercalciuric stone-forming rat |
| Q79931130 | Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-L-proline |
| Q34351298 | Nephrocalcinosis in animal models with and without stones |
| Q46426324 | Nephrolithiasis and nephrocalcinosis in rats with small bowel resection |
| Q39741115 | Nephrolithiasis: site of the initial solid phase |
| Q36618101 | New insights into the pathogenesis of idiopathic hypercalciuria |
| Q37181697 | Oxalate in renal stone disease: the terminal metabolite that just won't go away. |
| Q37913747 | Pathophysiology-based treatment of idiopathic calcium kidney stones |
| Q33568884 | Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium diet |
| Q34936294 | Pharmacology of stone disease |
| Q37336358 | Quantitative analysis of 4468 uroliths retrieved from farm animals, exotic species, and wildlife submitted to the Minnesota Urolith Center: 1981 to 2007. |
| Q34936316 | Recent advances in the pathophysiology of nephrolithiasis |
| Q46304096 | Roles of dietary glycine, proline, and hydroxyproline in collagen synthesis and animal growth |
| Q36076850 | Sex modifies genetic effects on residual variance in urinary calcium excretion in rat (Rattus norvegicus) |
| Q45936096 | Strain differences in urinary factors that promote calcium oxalate crystal formation in the kidneys of ethylene glycol-treated rats. |
| Q38788768 | Studies using a porcine model: what insights into human calcium oxalate stone formation mechanisms has this model facilitated? |
| Q51099842 | The effect of dietary hydroxyproline and dietary oxalate on urinary oxalate excretion in cats. |
| Q36763774 | The relation between bone and stone formation |
| Q89595922 | Vitamin D and Kidney Stones |
Search more.